Evidence map›Paper›PMID 28714876›Full record

Observational studyInternational journal of molecular sciences2017

Sustained Low Serum Substance P Levels in Non-Surviving Septic Patients.

Leonardo Lorente, María M Martín, Antonia Pérez-Cejas, José Ferreres, Jordi Solé-Violán, Lorenzo Labarta, César Díaz, Alejandro Jiménez

Open access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Inflammation and Organ Injury the Role of Substance P and Its Receptors.International journal of molecular sciences · 2023
    Review
  2. Observational
  3. Hydrogen Sulfide and Substance P Levels in Patients withInternational journal of molecular sciences · 2022
    Article
  4. Observational
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Leonardo LorenteIntensive Care Unit, Hospital Universitario de Canarias, Ofra, s/n. La Laguna, Tenerife 38320, Spain. lorentemartin@msn.com.
María M MartínIntensive Care Unit, Hospital Universitario Nuestra Señora Candelaria, Crta Rosario s/n. Santa Cruz Tenerife 38010, Spain. mar.martinvelasco@gmail.com.
Antonia Pérez-CejasLaboratory Deparment, Hospital Universitario de Canarias, Ofra, s/n. La Laguna, Tenerife 38320, Spain. aperezcejas@gmail.com.
José FerreresIntensive Care Unit, Hospital Clínico Universitario de Valencia, Avda, Blasco Ibáñez n° 17-19, Valencia 46004, Spain. ferreresj@gmail.com.
Jordi Solé-ViolánIntensive Care Unit, Hospital Universitario Dr. Negrín, Barranco de la Ballena s/n. Las Palmas de Gran Canaria 35010, Spain. jsolvio@gobiernodecanarias.org.
Lorenzo LabartaIntensive Care Unit, Hospital San Jorge de Huesca, Avenida Martínez de Velasco n° 36, Huesca 22004, Spain. llabarta@salud.aragon.es.
César DíazIntensive Care Unit, Hospital Insular, Plaza Dr. Pasteur s/n. Las Palmas de Gran Canaria 35016, Spain. incaicos@yahoo.es.
Alejandro JiménezResearch Unit, Hospital Universitario de Canarias, Ofra, s/n. La Laguna, Tenerife 38320, Spain. ajimenezsosa@gmail.com.
Hospital Universitario de Canarias · ESHospital Clínico Universitario de Valencia · ESHospital General San Jorge · ESHospital Universitario de Gran Canaria Doctor Negrín · ESHospital Universitario Insular de Gran Canaria · ESHospital Universitario Nuestra Señora de Candelaria · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previously, researchers found higher serum substance P (SP) concentrations in survivors of severe sepsis than in non-survivors at the time of severe sepsis diagnosis. The objectives of our current study were to determine whether there is an association between serum SP levels during the first week and sepsis mortality, sepsis severity, serum levels of tumor necrosis factor (TNF)-α and interleukin (IL)-10, and whether serum SP levels during the first week could be used as a biomarker of sepsis mortality. We determined serum concentration of SP, TNF-α, and IL-10 at days 1, 4, and 8. The end-point of the study was mortality at 30 days. We found that

Indexed as

HumansInterleukin-10Kaplan-Meier EstimateLogistic ModelsROC CurveSepsisSubstance PSurvivorsTumor Necrosis Factor-alphaIL10 protein, humanInterleukin-10Substance PTumor Necrosis Factor-alphamortalityoutcomepatientssepsissubstance P

Identifiers

PMID28714876
PMCPMC5536019
OpenAlexW2734985193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.